These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 16295429)

  • 1. Voluntary donors-need for a second look.
    Kakkar N; Kaur R; Dhanoa J
    Indian J Pathol Microbiol; 2004 Jul; 47(3):381-3. PubMed ID: 16295429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in western India.
    Garg S; Mathur DR; Garg DK
    Indian J Pathol Microbiol; 2001 Oct; 44(4):409-12. PubMed ID: 12035351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Infectious markers among blood donors in Democratic Republic of Congo (DRC)].
    Batina A; Kabemba S; Malengela R
    Rev Med Brux; 2007; 28(3):145-9. PubMed ID: 17708468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and trends of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in Delhi blood donors: a hospital based study.
    Pahuja S; Sharma M; Baitha B; Jain M
    Jpn J Infect Dis; 2007 Nov; 60(6):389-91. PubMed ID: 18032841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of transfusion transmitted infections in blood donors: an Indian experience.
    Chandra T; Kumar A; Gupta A
    Trop Doct; 2009 Jul; 39(3):152-4. PubMed ID: 19535750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of HIV, HBV, HCV and syphilis in blood donors in Southern Haryana.
    Arora D; Arora B; Khetarpal A
    Indian J Pathol Microbiol; 2010; 53(2):308-9. PubMed ID: 20551540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
    Kafi-abad SA; Rezvan H; Abolghasemi H; Talebian A
    Transfusion; 2009 Oct; 49(10):2214-20. PubMed ID: 19527477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
    Singh B; Verma M; Verma K
    Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of markers of transfusion transmissible diseases in voluntary and replacement blood donors.
    Sharma RR; Cheema R; Vajpayee M; Rao U; Kumar S; Marwaha N; Agnihotri SK
    Natl Med J India; 2004; 17(1):19-21. PubMed ID: 15115227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV, HCV, HBV and syphilis rate of positive donations among blood donations in Mali: lower rates among volunteer blood donors.
    Diarra A; Kouriba B; Baby M; Murphy E; Lefrere JJ
    Transfus Clin Biol; 2009; 16(5-6):444-7. PubMed ID: 19896404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalency of transfusion-transmitted infections in first-time volunteer and replacement donors in Tunisia.
    Ben Jemia R; Gouider E
    Transfus Clin Biol; 2014 Dec; 21(6):303-8. PubMed ID: 25458983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bloodborne infections among student voluntary blood donors in Mansoura University, Egypt.
    El-Gilany AH; El-Fedawy S
    East Mediterr Health J; 2006 Nov; 12(6):742-8. PubMed ID: 17333818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence and trends in transfusion transmissible infections among voluntary non-remunerated blood donors at the Malawi Blood Transfusion Service-a time trend study.
    M'baya B; Jumbe V; Samuel V; M'bwana R; Mangani C
    Malawi Med J; 2019 Jun; 31(2):118-125. PubMed ID: 31452844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence & changing trends of transfusion-transmitted infections amongst blood donors in a Regional Blood Transfusion Centre in north India.
    Rawat A; Diwaker P; Gogoi P; Singh B
    Indian J Med Res; 2017 Nov; 146(5):642-645. PubMed ID: 29512607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
    Erhabor O; Ejele OA; Nwauche CA
    Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectious pathogens in volunteer and replacement blood donors in Pakistan: a ten-year experience.
    Sultan F; Mehmood T; Mahmood MT
    Int J Infect Dis; 2007 Sep; 11(5):407-12. PubMed ID: 17331775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in transfusion-transmitted viral infections from 2001 to 2006 in Ibadan, Nigeria.
    Fasola FA; Kotila TR; Akinyemi JO
    Intervirology; 2008; 51(6):427-31. PubMed ID: 19321928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
    Nantachit N; Thaikruea L; Thongsawat S; Leetrakool N; Fongsatikul L; Sompan P; Fong YL; Nichols D; Ziermann R; Ness P; Nelson KE
    Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.